NEUROGENESIS AS A THERAPEUTIC TARGET FOR ALZHEIMER'S DISEASE

被引:6
|
作者
Fernandez-Verdecia, C. I. [3 ]
Diaz del Guante, M. A. [1 ]
Castillo-Diaz, L. [2 ]
Alvarez-Blanco, J. [4 ]
机构
[1] Univ Veracruzana, Inst Invest Psicol, Lab Neurociencia Restaurat, Xalapa 91190, Veracruz, Mexico
[2] Lab Cult Tejidos, Havana, Cuba
[3] Lab Biomodelos, Havana, Cuba
[4] Ctr Int Restaurac Neurol CIREN, Havana, Cuba
关键词
Alzheimer's disease; Environment; Hippocampus; Neurogenesis; Progenitor cell; Transplant; NEURAL STEM-CELLS; TRANSGENIC MOUSE MODEL; HIPPOCAMPAL NEUROGENESIS; SUBVENTRICULAR ZONE; ADULT NEUROGENESIS; PROGENITOR CELLS; CEREBRAL-CORTEX; RADIAL GLIA; AGED RAT; PROLIFERATION;
D O I
10.33588/rn.4904.2008632
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction. The adult brain of mammals preserves the capacity to generate new neurons front neural stem/progenitor cells. The new neurons become part of the already-existing networks by means of a process called 'neurogenesis in the adult brain', which is restricted to regions of the brain with a high degree of plasticity and which are associated to functions that are impaired in Alzheimer's disease. Development. Despite increasing knowledge, there are still many, questions surrounding these neurogenic phenomena, their regulation and their real therapeutic potential in cases of neurodegeneration such as the one referred to here. Conclusions. We have reviewed the subject of neurogenesis of the adult brain from both the pre-clinical point of view (experimental modelling) and the therapeutic perspective within the framework of Alzheimer's disease. [REV NEUROL 2009; 49: 193-201]
引用
收藏
页码:193 / 201
页数:9
相关论文
共 50 条
  • [1] The dentate gyrus neurogenesis: a therapeutic target for Alzheimer's disease
    Yoshitaka Tatebayashi
    Moon H. Lee
    Liang Li
    Khalid Iqbal
    Inge Grundke-Iqbal
    [J]. Acta Neuropathologica, 2003, 105 : 225 - 232
  • [2] The dentate gyrus neurogenesis: a therapeutic target for Alzheimer's disease
    Tatebayashi, Y
    Lee, MH
    Li, L
    Iqbal, K
    Grundke-Iqbal, I
    [J]. ACTA NEUROPATHOLOGICA, 2003, 105 (03) : 225 - 232
  • [3] Neurogenesis: A promising therapeutic target for Alzheimer disease and related disorders
    Grundke-Iqbal, I
    Tatebayashi, Y
    Lee, MH
    Li, L
    Iqbal, K
    [J]. Molecular Neurobiology of Alzheimer Disease and Related Disorders, 2004, : 172 - 182
  • [4] Aβ as a therapeutic target in Alzheimer's disease
    Buxbaum, J. D.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2001, 15 : 2 - 2
  • [5] Aneuploidy and adult neurogenesis in Alzheimer's disease: therapeutic strategies
    Taupin, Philippe
    [J]. DRUG DISCOVERY TODAY, 2010, 15 (23-24) : 983 - 984
  • [6] Neuroinflammation and Neurogenesis in Alzheimer's Disease and Potential Therapeutic Approaches
    Sung, Pi-Shan
    Lin, Po-Yu
    Liu, Chi-Hung
    Su, Hui-Chen
    Tsai, Kuen-Jer
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (03)
  • [7] Therapeutic potential of neurogenesis and melatonin regulation in Alzheimer's disease
    Mihardja, Mazel
    Roy, Jaydeep
    Wong, Kan Yin
    Aquili, Luca
    Heng, Boon Chin
    Chan, Ying-Shing
    Fung, Man Lung
    Lim, Lee Wei
    [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 2020, 1478 (01) : 43 - 62
  • [8] β-secretase as a therapeutic target for Alzheimer's disease
    Ghosh, Arun K.
    Gemma, Sandra
    Tang, Jordan
    [J]. NEUROTHERAPEUTICS, 2008, 5 (03) : 399 - 408
  • [9] β-Secretase as a therapeutic target for Alzheimer’s disease
    Arun K. Ghosh
    Sandra Gemma
    Jordan Tang
    [J]. Neurotherapeutics, 2008, 5 : 399 - 408
  • [10] Hypometabolism as a therapeutic target in Alzheimer's disease
    Costantini, Lauren C.
    Barr, Linda J.
    Vogel, Janet L.
    Henderson, Samuel T.
    [J]. BMC NEUROSCIENCE, 2008, 9 (Suppl 2)